West Pharmaceutical Servs Q3 Adj. EPS $2.66 Beats $2.19 Estimate, Sales $874.500M Beat $825.700M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Beats
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $2.19 by 21.46 percent. This is a 35.71 percent increase over earnings of $1.96 per share
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $2.19 by 21.46 percent. This is a 35.71 percent increase over earnings of $1.96 per share from the same period last year. The company reported quarterly sales of $874.500 million which beat the analyst consensus estimate of $825.700 million by 5.91 percent. This is a 8.69 percent increase over sales of $804.600 million the same period last year.